Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel TAP Block in Open Abdomen Surgery
NCT03878888Phase 4Completed
- Sponsor
- St. Luke's Hospital
- Start
- Jan 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by St. Luke's Hospital. Primary endpoints: Oral Morphine Equivalents (OME) and Postoperative Pain Scores. Started Jan 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03878888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878888.